Concepedia

Mark Klinger

MK

27

Publications

4.1K

Citations

25

H-Index

2000

Active since

Affiliations

Adaptive Biotechnologies (United States)(Current)

University of California, San Francisco

University of Washington

National Institutes of Health

Institute for Systems Biology

Mark Klinger is an author at Adaptive Biotechnologies (United States) specializing in medicine, immunology, and autoimmunity.

Top concepts

Publications per year

2000–2025

27

Publications

27

Multiple early factors anticipate post-acute COVID-19 sequelae

Yapeng Su, Dan Yuan, Daniel Chen et al. · Cell · 2022 · 1.1K citations · Full text

Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire

Ryan Emerson, William S. DeWitt, Marissa Vignali et al. · Nature Genetics · 2017 · 575 citations

, , +8

Improved Survival with T Cell Clonotype Stability After Anti–CTLA-4 Treatment in Cancer Patients

Edward Cha, Mark Klinger, Yafei Hou et al. · Science Translational Medicine · 2014 · 376 citations · Full text

Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire

David Y. Oh, Jason Cham, Li Zhang et al. · Cancer Research · 2016 · 239 citations

Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels

Thomas M. Snyder, Rachel M. Gittelman, Mark Klinger et al. · 2020 · 233 citations · Full text

, , +18

Rows per page

1–5 of 27